IGTHERAPEUTICS Trademark

Trademark Overview

On Thursday, April 18, 2019, a trademark application was filed for IGTHERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the IGTHERAPEUTICS trademark a serial number of 88391549. The federal status of this trademark filing is REGISTERED as of Tuesday, August 18, 2020. This trademark is owned by Intact Genomics, Inc.. The IGTHERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development
igtherapeutics

General Information

Serial Number88391549
Word MarkIGTHERAPEUTICS
Filing DateThursday, April 18, 2019
Status700 - REGISTERED
Status DateTuesday, August 18, 2020
Registration Number6131275
Registration DateTuesday, August 18, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 24, 2019

Trademark Statements

Goods and ServicesPharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development
Pseudo MarkINTACT GENOMICS THERAPEUTICS

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, May 4, 2019
Primary Code042
First Use Anywhere DateWednesday, June 10, 2020
First Use In Commerce DateWednesday, June 10, 2020

Trademark Owner History

Party NameIntact Genomics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSaint Louis, MO 63132
Party NameIntact Genomics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSaint Louis, MO 63132
Party NameIntact Genomics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSaint Louis, MO 63132

Trademark Events

Event DateEvent Description
Tuesday, August 18, 2020REGISTERED-PRINCIPAL REGISTER
Wednesday, July 15, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, July 14, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, July 6, 2020STATEMENT OF USE PROCESSING COMPLETE
Thursday, June 11, 2020USE AMENDMENT FILED
Thursday, July 2, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, June 11, 2020TEAS STATEMENT OF USE RECEIVED
Tuesday, February 18, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 24, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 24, 2019PUBLISHED FOR OPPOSITION
Wednesday, December 4, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 20, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 19, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 13, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 19, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, November 19, 2019ASSIGNED TO LIE
Wednesday, November 13, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 29, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 29, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, June 9, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, June 9, 2019NON-FINAL ACTION E-MAILED
Sunday, June 9, 2019NON-FINAL ACTION WRITTEN
Sunday, June 9, 2019ASSIGNED TO EXAMINER
Saturday, May 4, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, April 22, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

igtherapeutics pharmaceutical development research products services drug